The Japan Times - McKinsey to pay $650 mn to settle US criminal case on opioids

EUR -
AED 4.029739
AFN 70.778474
ALL 89.669173
AMD 395.464045
ANG 1.96456
AOA 1007.296808
ARS 1720.666958
AUD 1.64558
AWG 1.977834
AZN 1.86972
BAM 1.955128
BBD 2.206341
BDT 136.253158
BGN 1.945981
BHD 0.413358
BIF 3299.465689
BMD 1.097273
BND 1.413214
BOB 12.789603
BRL 6.528229
BSD 1.095423
BTN 101.462119
BWP 15.618631
BYN 3.288669
BYR 21506.546342
BZD 2.203143
CAD 1.574203
CDF 2501.782318
CHF 0.922196
CLF 0.028442
CLP 1116.636116
CNY 7.327314
CNH 7.332859
COP 3761.106983
CRC 490.331431
CUC 1.097273
CUP 26.290962
CVE 110.227105
CZK 24.468858
DJF 195.072937
DKK 7.47781
DOP 66.08728
DZD 149.391641
EGP 58.61085
ERN 16.459092
ETB 179.797988
FJD 2.514456
FKP 0.838778
GBP 0.838894
GEL 2.857146
GGP 0.838778
GHS 12.898566
GIP 0.838778
GMD 81.198575
GNF 9711.661263
GTQ 8.373121
GYD 229.181211
HKD 8.601467
HNL 29.444877
HRK 7.496529
HTG 143.650615
HUF 373.391377
IDR 20072.355965
ILS 3.666044
IMP 0.838778
INR 101.695794
IQD 1660.729064
IRR 2125817.320551
ISK 137.28022
JEP 0.838778
JMD 173.530343
JOD 0.77801
JPY 173.978128
KES 142.461024
KGS 95.956926
KHR 4469.463459
KMF 492.675859
KPW 987.545879
KRW 1476.824954
KWD 0.342108
KYD 0.912886
KZT 499.698211
LAK 24694.510363
LBP 98101.274117
LKR 364.304757
LRD 183.48692
LSL 19.148917
LTL 3.239962
LVL 0.66373
LYD 7.087563
MAD 10.954734
MDL 20.079097
MGA 4964.293344
MKD 61.533846
MMK 2304.580358
MNT 3959.266389
MOP 8.844159
MRU 44.651649
MUR 51.330836
MVR 16.902103
MWK 1899.546962
MXN 21.022046
MYR 4.513125
MZN 70.119822
NAD 19.148917
NGN 1486.804984
NIO 40.31614
NOK 10.711083
NPR 162.33919
NZD 2.006534
OMR 0.418806
PAB 1.095423
PEN 3.760307
PGK 4.931305
PHP 70.245251
PKR 302.809298
PLN 4.459811
PYG 6907.625252
QAR 4.004323
RON 5.352281
RSD 117.589574
RUB 89.402865
RWF 1618.343635
SAR 4.116755
SBD 8.914258
SCR 15.355277
SDG 660.013606
SEK 11.223898
SGD 1.414828
SHP 0.838605
SLE 25.07309
SLL 23009.265425
SOS 626.084761
SRD 40.997955
STD 22711.331007
STN 24.49158
SVC 9.584705
SYP 14266.740959
SZL 19.144418
THB 37.356693
TJS 10.072637
TMT 3.840455
TND 3.318059
TOP 2.64197
TRY 55.454853
TTD 7.435444
TWD 36.176649
TZS 2922.095423
UAH 49.196787
UGX 4628.408816
USD 1.097273
UYU 44.544686
UZS 13114.491416
VES 1006.876973
VND 28311.283441
VUV 132.579834
WST 3.09791
XAF 655.957
XAG 0.026772
XAU 0.000311300718
XCD 2.965435
XCG 1.974321
XDR 0.775829
XOF 655.957
XPF 119.331742
YER 259.618676
ZAR 19.332389
ZMK 9876.775613
ZMW 22.555246
ZWL 353.321385
SSP 6337.564166
MXV 2.356505
  • RYCEF

    0.1000

    19.81

    +0.5%

  • VOD

    -0.2500

    16.33

    -1.53%

  • CMSC

    -0.2800

    20.12

    -1.39%

  • RBGPF

    -2.0000

    65

    -3.08%

  • RIO

    -0.2500

    94.16

    -0.27%

  • BTI

    -1.2000

    54.85

    -2.19%

  • NGG

    -0.3000

    74.94

    -0.4%

  • GSK

    -0.3500

    49.35

    -0.71%

  • BCE

    -0.4200

    20.14

    -2.09%

  • CMSD

    -0.3400

    19.93

    -1.71%

  • BP

    -0.9100

    43.52

    -2.09%

  • RELX

    0.1700

    33.24

    +0.51%

  • BCC

    -0.6200

    75.97

    -0.82%

  • AZN

    -1.9400

    164.21

    -1.18%

  • JRI

    0.0000

    10.77

    0%

McKinsey to pay $650 mn to settle US criminal case on opioids
McKinsey to pay $650 mn to settle US criminal case on opioids / Photo: Fabrice COFFRINI - AFP/File

McKinsey to pay $650 mn to settle US criminal case on opioids

Consulting giant McKinsey & Company will pay $650 million to settle US criminal charges that it collaborated with Purdue Pharma to intentionally misbrand opioids, worsening a public health crisis, officials announced Friday.

Text size:

US prosecutors unveiled a sweeping deferred prosecution agreement (DPA) over McKinsey efforts that helped Purdue "turbocharge" sales of the highly addictive OxyContin opioid, responsible for deadly overdoses.

The accord, which requires McKinsey to implement a comprehensive compliance program, represents the "first time a management consulting firm has been held criminally responsible for advice that it has given resulting in the commission of a crime by a client," said US Attorney Christopher Kavanaugh, of the Western District of Virginia, speaking at a news conference.

Additionally, prosecutors charged McKinsey US with one felony count of knowingly destroying evidence with an intent to impede a probe and a misdemeanor of knowingly conspiring with Purdue to abet the misbranding of drugs, the Justice Department said.

The DPA, which will expire in five years if McKinsey meets the conditions, also noted that a senior partner with the prominent consultancy "knowingly" destroyed and hid records with the "intent to impede, obstruct and influence" the probe.

Prosecutors said the former McKinsey partner, Martin Elling, had agreed to plead guilty in the case.

From 1999 through 2022 nearly 727,000 people died from opioid overdoses, according to the Centers for Disease Control and Prevention.

McKinsey expressed regret for the firm's role in the scandal.

"We are deeply sorry for our past client service to Purdue Pharma and the actions of a former partner who deleted documents related to his work for that client," McKinsey said in a statement. "We should have appreciated the harm opioids were causing in our society and we should not have undertaken sales and marketing work for Purdue Pharma."

McKinsey has bolstered its risk management practices, it said, adding, "though we wish we had taken these steps sooner, we are committed to building on them to ensure that McKinsey sets the standard for accountability and compliance across our profession."

Friday's announcement comes about a week after US prosecutors in New York unveiled a nearly $123 million settlement with McKinsey and Co. Africa in a separate DPA, over charges the subsidiary paid bribes to South African officials to obtain lucrative consulting contracts.

- 'High- Value Prescribers'-

Kavanaugh described McKinsey as intimately involved in efforts to boost OxyContin sales after they fell off following a 2007 US settlement with Purdue over criminally misbranding the drug.

Undertaking a study for client Purdue, McKinsey determined that the sales dropped due to concerns by doctors and pharmacists that the drug was being abused.

"To turbocharge sales, McKinsey devised, and Purdue followed, the targeting of High Value Prescribers, including those who are prescribing opioids for uses that were unsafe, ineffective and medically unnecessary," Kavanaugh said.

"This was not just marketing," he added. "It was strategy. It was executed and it worked."

The settlement requires McKinsey to establish and provide updates on a compliance program that involves employee training and risk-assessment reviews of potential clients. The company must also undertake new document retention policies.

Such measures constitute "a full infrastructure of what professional services firms are expected to do to make sure they don't end up in this situation," said US Attorney Joshua Levy.

McKinsey also agreed not to do any work "related to the marketing, sale, promotion or distribution of controlled substances," the filing said.

Friday's criminal agreement comes on the heels of earlier civil McKinsey settlements over its conduct relating to Purdue.

In February 2021, McKinsey agreed to pay $573 million to settle claims brought by 47 states and five US territories that it contributed to the opioid crisis through its advice to pharmaceutical giants.

In September 2023, McKinsey agreed to an additional $230 million in settlements with US municipalities, counties and public school districts.

S.Yamada--JT